Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Immunology Letters|January 31, 1989
Cytotoxic endothelial cell antibodies in mixed connective tissue diseaseE Bodolay, F Bojan, G Szegedi, et al.
Experimental and Clinical Immunogenetics|January 1, 1985
The association of IgG heavy-chain allotypes (Gm) with Graves' disease in HungaryL Kozma, V Stenszky, E Kraszits, et al.
Orvosi Hetilap|February 12, 1998
[Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy]C Balázs, E Kiss, A Vámos, et al.
Endocrine|December 15, 2010
Gene usage and regulation of Gsα gene expression in thyroid cellsM Zou, Y Shi, S T Al-Sedairy, et al.
Endocrinology|July 1, 1983
Both TSH and thyroid-stimulating antibody of Graves' disease bind to an Mr 197,000 holoreceptorM N Islam, R Briones-Urbina, G Bakó, et al.
Human Heredity|January 1, 1980
Polymorphism of the second component of complement (C2) in Graves' diseaseE P Noel, L Sampson, B M Pepper, et al.
Cancer|July 1, 1986
The relation of susceptibility to and biologic behavior of thyroid epithelial cell cancer to HLA-DR1F Juhasz, G Balázs, V Stenszky, et al.
British Journal of Cancer|November 1, 1996
Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomasY Shi, M Zou, N R Farid, et al.
American Journal of Medical Genetics|July 31, 2001
Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studiesM Marga, A Denisova, A Sochnev, et al.
Endocrine|July 17, 1998
Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomasM Zou, Y Shi, N R Farid, et al.
Pageof 16